Dementia May Occur Less Often, Develop Slower in Parkinson Disease Patients
Median time to dementia was 15 years in Penn cohort; estimated probability of dementia at year 10 was 9 to 15 percent in PPMI cohort
Chronic and New-Onset Anxiety Linked to All-Cause Dementia
Associations seen for chronic and new-onset anxiety, but not for resolved anxiety, with all-cause dementia risk
Complex Interaction Seen Between Social Determinants of Health, Mortality
A scoring system can help identify individuals at high risk for mortality based on their combination of social determinants of health
Vestibular Neurectomy Effective for Severe Meniere Disease
Significant benefits seen in physical and functional outcomes two years after neurectomy
Neuro/Psych Diagnoses Prevalent in Children With Medical Complexity
Findings highlight importance of addressing neurodevelopmental and mental health conditions in this population
MR-Guided Focused Ultrasound Thalamotomy Beneficial for Essential Tremor
Improvement seen in mean tremor/motor score from 17.4 to 6.4 at three months with use of MR-guided, focused ultrasound thalamotomy
Fecal Microbiota Transplant No Aid for Parkinson Disease
At six months, no significant changes seen in Movement Disorder Society Unified Parkinson’s Disease Rating Scale scores versus placebo
Population-Level Interventions Cost-Effective for Reducing Risk for Dementia
Interventions could reduce risk factors for dementia, resulting in cost-savings and gain in quality-adjusted life years
Pharmacist Prescribing Can Reduce Stroke Risk in A-Fib Patients
Findings seen for pharmacist prescribing compared with usual care in older adults at high risk for stroke
Plasma Biomarkers of Alzheimer Neuropathy Linked to Dementia Risk
Significant associations seen for all Alzheimer disease plasma biomarkers in late life with late-life dementia
